Get the Stockscreener App
9.69
1.93%
0.86
Burning Rock Biotech Ltd Adr stock is traded at $9.69, with a volume of 2,447.
It is up +1.93% in the last 24 hours and down -9.73% over the past month.
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
See More
Previous Close:
$8.83
Open:
$9.18
24h Volume:
2,447
Relative Volume:
0.13
Market Cap:
$95.97M
Revenue:
$72.33M
Net Income/Loss:
$-8.38M
P/E Ratio:
-12.30
EPS:
-0.7881
Net Cash Flow:
$-4.95M
1W Performance:
-17.10%
1M Performance:
-9.73%
6M Performance:
-69.54%
1Y Performance:
+20.32%
1-Day Range:
$8.88
$9.18
1-Week Range:
$8.83
$11.13
52-Week Range:
$6.79
$41.72
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Name
Burning Rock Biotech Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare BNR vs TMO, DHR, NTRA, IDXX, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
9.10 | 93.12M | 72.33M | -8.38M | -4.95M | -0.7881 |
TMO
Thermo Fisher Scientific Inc
|
587.06 | 217.52B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.36 | 142.32B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
314.99 | 44.67B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
544.89 | 43.41B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.97 | 41.95B | 7.23B | 1.41B | 1.09B | 4.979 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jul-07-20 | Initiated | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Stock (BNR) Latest News
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 3.7%What's Next? - MarketBeat
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – FWB:6BU0 - TradingView
Burning Rock Biotech Limited Sponsored ADR $BNR Shares Sold by Crcm LP - MarketBeat
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to EBITDA forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Burning Rock CEO purchases $618,218 in company shares - Investing.com
Burning Rock Biotech Ltd. Sponsored ADR Financial Disclosures & Filings - TradingView
Enterprise value to EBIT forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to book forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to earnings forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:BNR) - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (LS:A40AE6) - TradingView
Why These High-Flying Stocks Came Back To Earth - Sahm
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01Momentum ETF - newsline.com
ETFs Investing in Burning Rock Biotech Ltd. Sponsored ADR Stocks - TradingView
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Update - MarketBeat
Burning Rock Biotech (NASDAQ: BNR) 2025 loss narrows amid China and HFCAA risks - Stock Titan
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 1.3%What's Next? - MarketBeat
Cancer screening company Faces Tough IPO Test As Market Cools - Benzinga
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer By Investing.com - Investing.com South Africa
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer - Investing.com
Burning Rock Biotech (NASDAQ:BNR) Director Purchases $5,466,143.20 in Stock - MarketBeat
Burning Rock CEO purchases $546,604 in company shares - Investing.com
Burning Rock CEO purchases $546,604 in company shares By Investing.com - Investing.com India
Burning Rock Biotech (BNR) Expected to Announce Earnings on Tuesday - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 9.8%Here's What Happened - MarketBeat
(BNR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Burning Rock Biotech (BNR) Stock Price, News & Analysis $BNR - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Trading Down 9.7%Here's What Happened - MarketBeat
Intel and AMD among market cap stock movers on Friday By Investing.com - Investing.com Australia
Intel, Iris Energy among market cap stock movers on Friday - Investing.com
Alibaba and Facebook among market cap stock movers on Thursday - Investing.com
Burning Rock Announces Results of 2025 Annual General Meeting - ChartMill
This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs - Yahoo Finance
KindlyMD (NAKA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
BNR: Revenue up 9.6% and net loss narrowed, with strong pharma R&D and cost controls - TradingView
BNR: Net loss narrowed 89% year-over-year as pharma R&D revenue surged and margins improved - TradingView
BNR: 2024 revenue fell 4% to RMB515.8M, net loss narrowed 47%, in-hospital segment now leads - TradingView
BNR: Commercial breakeven reached in FY2024, with strong margins and leadership in early cancer detection - TradingView
BNR: Net loss narrowed and gross margin improved as in-hospital and pharma R&D revenues grew - TradingView
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China - ChartMill
BNR: In-hospital revenue rose 11.2% and net loss narrowed as the business shifted away from central-lab testing - TradingView
Japan Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock Biotech Ltd Share Price ADR Each Representing 10 Ord A Shares SPON - Hargreaves Lansdown
symbol__ Stock Quote Price and Forecast - CNN
Recent Insider BuyingStock ScreenerSnapshot - Finviz
These stocks are moving in today's after hours session - ChartMill
What is the current Price Target and Forecast for Burning Rock Biotech (BNR) - Zacks Investment Research
Which stocks are gapping on Monday? - ChartMill
Burning Rock Biotech Ltd Adr Stock (BNR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Burning Rock Biotech Ltd Adr Stock (BNR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Han Yusheng | Director |
Jun 12 '26 |
Buy |
9.25 |
210,000 |
1,942,143 |
17,907,436 |
| Han Yusheng | Director |
Jun 16 '26 |
Buy |
9.00 |
111,110 |
999,957 |
18,018,546 |
| Han Yusheng | Director |
Jun 22 '26 |
Buy |
7.45 |
104,650 |
779,674 |
18,123,196 |
| Han Yusheng | Director |
Jun 11 '26 |
Buy |
8.74 |
24,760 |
216,388 |
17,697,436 |
| Han Yusheng | Director |
Jun 26 '26 |
Buy |
8.00 |
24,900 |
199,090 |
18,404,086 |
| Han Yusheng | Director |
Jun 23 '26 |
Buy |
7.50 |
5,990 |
44,920 |
18,129,186 |
| Han Yusheng | Director |
Mar 31 '26 |
Buy |
17.36 |
314,870 |
5,466,143 |
17,672,676 |
1.81%
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):